Pulmonary vascular remodeling and right heart failure in pulmonary hypertension: future role of positron emission tomography in decoding the enigma

  • Harms H
  • van de Veerdonk M
  • Lammertsma A
  • et al.
N/ACitations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Whereas the insights into the cellular and molecular mechanisms of pulmonary arterial hypertension (PAH) and associated right heart failure have increased in recent years, there is a lack of clinical tools to assess the pathobiological mechanisms in patients. Positron emission tomography (PET) provides an array of new possibilities to image and quantify relevant disease processes, including proliferation, angiogenesis, matrix remodeling, shifts in metabolism and neurohormonal signaling. Here we describe the first studies which were conducted to image pulmonary vascular remodeling and right heart failure in vivo and discuss additional targets for imaging which hold great promise for future use in PAH patients.

Cite

CITATION STYLE

APA

Harms, H. J., van de Veerdonk, M. C., Lammertsma, A. A., Noordegraaf, A. V., & Bogaard, H. J. (2013). Pulmonary vascular remodeling and right heart failure in pulmonary hypertension: future role of positron emission tomography in decoding the enigma. Translational Respiratory Medicine, 1(1). https://doi.org/10.1186/2213-0802-1-16

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free